Skip to content

Effectiveness of herbal eye poultices on headache pain and ocular symptoms among patients with migraine

Effectiveness of herbal eye poultices on headache pain and ocular symptoms among patients with migraine

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250309015
Enrollment
60
Registered
2025-03-09
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

headache pain and ocular symptoms among patients with migraine headache pain ocular symptoms migraine

Interventions

Using herbal eye poultices, Andrographis paniculata powder among patients with migraine,Massage therapy among patients with migraine among patients with migraine
herbal eye poultices,Massage therapy

Sponsors

Department of Thai Traditional and Alternative Medicine
Lead Sponsor
school of public health
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18-60 years, both males and females 2. Headache from the Visual Analog Scale (VAS) pain measurement score of 4 or higher 3. Have pain in the eyeball, blurred vision, or see glittering lights 4. Have no history of herbal allergies 5. No vomiting 6. Do not receive specific painkillers for migraine, such as triptans, ergot alkaloids 7. Voluntarily participate in the project and sign the consent form to participate in the research project

Exclusion criteria

Exclusion criteria: 1. Unable to participate in activities for the specified period and number of times. 2. Having a sudden illness, such as a serious infectious disease, an accident, or the need to undergo surgery. 3. Having received alternative treatments, such as acupuncture, specific medication for migraines, etc.

Design outcomes

Primary

MeasureTime frame
headache pain at 4 weeks after end of the intervention Visual Analog Scale (VAS) ,ocular symptoms at 4 weeks after end of the intervention Patient reported outcome using a questionnaire interview

Secondary

MeasureTime frame
Frequency of headaches at 4 weeks after end of the intervention time,Duration of headaches at 4 weeks after end of the intervention minute

Countries

Thailand

Contacts

Public Contactpakorn pusuwan

school of public health University of Phayao

pakorn.pu@up.ac.th0870537137

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026